Treffer 1 - 6 von 6 für Suche 'PARIZADEH, Dari', Suchdauer: 0,39s Treffer weiter einschränken
  1. 1
    Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System

    Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System von Quesada, Gabriel, Chang, Daniel H, Waltz, Kevin L, Kao, Andrew A, Quesada, Rodrigo, Wang, Ying, Ji, Leilei, Parizadeh, Dari, Atiles, Luis


    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  2. 2
    Effects of tazarotene 0.1% cream in the treatment of facial acne vulgaris: Pooled results from Two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials

    Effects of tazarotene 0.1% cream in the treatment of facial acne vulgaris: Pooled results from Two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials von SHALITA, Alan R, BERSON, Diane S, THIBOUTOT, Diane M, LEYDEN, James J, PARIZADEH, Dari, SEFTON, John, WALKER, Patricia S, GIBSON, John R

    Veröffentlicht in Clinical therapeutics

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  3. 3
    Effects of tazarotene 0.1 % cream in the treatment of facial acnevulgaris: Pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials

    Effects of tazarotene 0.1 % cream in the treatment of facial acnevulgaris: Pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials von Shalita, Alan R, Berson, Diane S, Thiboutot, Diane M, Leyden, James J, Parizadeh, Dari, Sefton, John, Walker, Patricia S., Gibson, John R.

    Veröffentlicht in Clinical therapeutics

    Volltext
    Artikel

    Zu den Favoriten
    Gespeichert in:
  4. 4
    Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System

    Clinical Performance and Surgeon Acceptability of a New Dual Mode Phacoemulsification System von Quesada, Gabriel, Chang, Daniel H, Waltz, Kevin L, Kao, Andrew A, Quesada, Rodrigo, Wang, Ying, Ji, Leilei, Parizadeh, Dari, Atiles, Luis


    Volltext
    Report

    Zu den Favoriten
    Gespeichert in:
  5. 5
    THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC PH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z

    THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC PH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z von SEFTON JOHN, PARIZADEH DARI D, YU DALE K, TANG-LIU DIANE, LEE EDWARD

    Volltext bestellen
    Patent

    Zu den Favoriten
    Gespeichert in:
  6. 6
    THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z

    THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z von SEFTON JOHN, PARIZADEH DARI D, YU DALE K, TANG-LIU DIANE, LEE EDWARD

    Volltext bestellen
    Patent

    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: